QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
NASDAQ:HLTH

Cue Health - HLTH Stock Forecast, Price & News

$3.07
-0.11 (-3.46%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.03
$3.23
50-Day Range
$2.49
$4.10
52-Week Range
$2.42
$16.20
Volume
370,136 shs
Average Volume
664,328 shs
Market Capitalization
$458.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Cue Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
128.0% Upside
$7.00 Price Target
Short Interest
Healthy
3.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.04mentions of Cue Health in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$949,470 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.34) to ($1.98) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Medical Sector

339th out of 1,023 stocks

Analytical Instruments Industry

10th out of 28 stocks

HLTH stock logo

About Cue Health (NASDAQ:HLTH) Stock

Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Receive HLTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cue Health and its competitors with MarketBeat's FREE daily newsletter.

HLTH Stock News Headlines

Cue Health, Inc. (HLTH) Q3 2022 Earnings Call Transcript
Cue Health Third Quarter 2022 Earnings: Beats Expectations
Cue Health Reports Third Quarter 2022 Results
Cue Health Inc. (HLTH) Upgraded to Buy: Here's Why
Cue Health Inc. (HLTH)
Cue Health Reports Second Quarter 2022 Results
Cue Health Inc.
See More Headlines
Receive HLTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cue Health and its competitors with MarketBeat's FREE daily newsletter.

HLTH Company Calendar

Last Earnings
11/09/2022
Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
4/04/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HLTH
Fax
N/A
Employees
1,585
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+128.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$86.42 million
Pretax Margin
-27.09%

Debt

Sales & Book Value

Annual Sales
$618.11 million
Cash Flow
$1.35 per share
Book Value
$4.83 per share

Miscellaneous

Free Float
105,499,000
Market Cap
$458.76 million
Optionable
Optionable
Beta
1.12

Key Executives

  • Mr. Ayub K. Khattak (Age 37)
    Co-Founder, Pres, CEO & Chairman
    Comp: $9.4M
  • Mr. Clint Sever (Age 37)
    Co-Founder & Chief Product Officer
    Comp: $4.35M
  • Mr. Christopher K. Achar (Age 36)
    Chief Strategy Officer & Director
    Comp: $200.82k
  • Mr. John E. Gallagher (Age 49)
    Chief Financial Officer
  • Mr. David Arida
    Chief Operating Officer
  • Ms. Erica Palsis Esq. (Age 37)
    Gen. Counsel & Corp. Sec.
  • Ms. Dena Cook
    Chief Communications Officer
  • Ms. Eileen Sheil
    Chief Communications Officer
  • Mr. Nitin Duggal
    Chief Marketing Officer
  • Ms. Elizabeth Swanson
    VP of People & Culture













HLTH Stock - Frequently Asked Questions

Should I buy or sell Cue Health stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HLTH shares.
View HLTH analyst ratings
or view top-rated stocks.

What is Cue Health's stock price forecast for 2023?

4 equities research analysts have issued 12 month target prices for Cue Health's stock. Their HLTH share price forecasts range from $6.00 to $8.00. On average, they predict the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 118.1% from the stock's current price.
View analysts price targets for HLTH
or view top-rated stocks among Wall Street analysts.

How have HLTH shares performed in 2022?

Cue Health's stock was trading at $13.41 at the beginning of 2022. Since then, HLTH stock has decreased by 76.1% and is now trading at $3.21.
View the best growth stocks for 2022 here
.

Are investors shorting Cue Health?

Cue Health saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 3,090,000 shares, a decline of 26.1% from the October 31st total of 4,180,000 shares. Based on an average daily trading volume, of 425,300 shares, the days-to-cover ratio is presently 7.3 days. Approximately 3.6% of the shares of the company are short sold.
View Cue Health's Short Interest
.

When is Cue Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 4th 2023.
View our HLTH earnings forecast
.

How were Cue Health's earnings last quarter?

Cue Health Inc. (NASDAQ:HLTH) issued its quarterly earnings data on Wednesday, November, 9th. The company reported ($0.43) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.55) by $0.12. The company earned $69.59 million during the quarter, compared to the consensus estimate of $58.03 million. Cue Health had a negative net margin of 24.25% and a negative trailing twelve-month return on equity of 12.29%.

What guidance has Cue Health issued on next quarter's earnings?

Cue Health updated its fourth quarter 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $45.00 million-$50.00 million, compared to the consensus revenue estimate of $69.02 million.

When did Cue Health IPO?

(HLTH) raised $200 million in an initial public offering on Friday, September 24th 2021. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share.

What is Cue Health's stock symbol?

Cue Health trades on the NASDAQ under the ticker symbol "HLTH."

Who are Cue Health's major shareholders?

Cue Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Oakmont Corp (6.48%), BlackRock Inc. (4.41%), Vanguard Group Inc. (2.70%), State Street Corp (1.10%), Nuveen Asset Management LLC (0.26%) and Bank of New York Mellon Corp (0.22%).
View institutional ownership trends
.

How do I buy shares of Cue Health?

Shares of HLTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cue Health's stock price today?

One share of HLTH stock can currently be purchased for approximately $3.21.

How much money does Cue Health make?

Cue Health (NASDAQ:HLTH) has a market capitalization of $479.67 million and generates $618.11 million in revenue each year. The company earns $86.42 million in net income (profit) each year or ($0.88) on an earnings per share basis.

How many employees does Cue Health have?

The company employs 1,585 workers across the globe.

How can I contact Cue Health?

Cue Health's mailing address is 4980 CARROLL CANYON ROAD SUITE 100, SAN DIEGO CA, 92121. The official website for the company is www.cuehealth.com. The company can be reached via phone at 858-412-8151 or via email at ir@cuehealth.com.

This page (NASDAQ:HLTH) was last updated on 12/6/2022 by MarketBeat.com Staff